Eyeberia

Especialitat

Retina i Vitri

Títol complet

A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) with Diabetic Macular Edema

Promotor

ALLERGAN

Data d'inici

Novembre 2019

Investigadors

Principal: Dr. Rafael Navarro

Co-Investigadors: Dra. Anniken Burés, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas